MKCPX
Price
$27.49
Change
-$0.04 (-0.15%)
Updated
Nov 13 closing price
RLBGX
Price
$36.66
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

MKCPX vs RLBGX

Header iconMKCPX vs RLBGX Comparison
Open Charts MKCPX vs RLBGXBanner chart's image
BlackRock Sustainable Balanced K
Price$27.49
Change-$0.04 (-0.15%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R6
Price$36.66
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MKCPX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MKCPX vs. RLBGX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKCPX is a StrongBuy and RLBGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 240B vs. MKCPX (1.66B). MKCPX pays higher dividends than RLBGX: MKCPX (2.93) vs RLBGX (2.55). MKCPX was incepted earlier than RLBGX: MKCPX (7 years) vs RLBGX (16 years). RLBGX is a more actively managed with annual turnover of: 171.00 vs. MKCPX (152.00). RLBGX has a lower initial minimum investment than MKCPX: RLBGX (250) vs MKCPX (5000000). RLBGX annual gain was more profitable for investors over the last year : 23.04 vs. MKCPX (21.23). RLBGX return over 5 years is better than : 38.63 vs. MKCPX (25.85).
MKCPXRLBGXMKCPX / RLBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years16 years-
Gain YTD14.06015.93588%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B240B1%
Annual Yield % from dividends2.932.55115%
Returns for 1 year21.2323.0492%
Returns for 3 years-1.5112.77-12%
Returns for 5 years25.8538.6367%
Returns for 10 yearsN/A56.10-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RARE48.720.88
+1.84%
Ultragenyx Pharmaceutical
BCS13.21-0.01
-0.08%
Barclays PLC
PUBM16.27-0.15
-0.94%
PubMatic
MRKR3.64-0.08
-2.15%
Marker Therapeutics
EDAP2.55-0.09
-3.41%
EDAP TMS SA